世界の細胞療法市場予測(~2025年)

• 英文タイトル:Global Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025「世界の細胞療法市場予測(~2025年)」(市場規模、市場予測)調査レポートです。• レポートコード:GIR201113827
• 出版社/出版日:GlobalInfoResearch / 2020年10月
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥396,720 (USD3,480)▷ お問い合わせ
  Multi User¥595,080 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、細胞療法の世界市場を調査対象にし、細胞療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(幹細胞、非幹細胞)、用途別分析(病院、クリニック)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Gilead Sciences、Beike Biotechnology、Vericel Corporation、Novartis、JCR Pharmaceuticals、Osiris、Guanhao Biotech、Fujifilm Cellular Dynamics、Vcanbio、Golden Meditech
・企業別売上、市場シェア
・細胞療法の地域別市場分析
・細胞療法の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・細胞療法のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・細胞療法のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・細胞療法の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・細胞療法の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・細胞療法の種類別市場規模2015-2020:幹細胞、非幹細胞
・細胞療法の用途別市場規模2015-2020:病院、クリニック
・細胞療法の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 25.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 200290 million by 2025, from USD 79730 million in 2019.

Market segmentation
Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cell Therapy market has been segmented into:
Stem Cell
Non-Stem Cell

By Application, Cell Therapy has been segmented into:
Hospital
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Cell Therapy Market Share Analysis
Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Cell Therapy are:
Gilead Sciences
Beike Biotechnology
Vericel Corporation
Novartis
JCR Pharmaceuticals
Osiris
Guanhao Biotech
Fujifilm Cellular Dynamics
Vcanbio
Golden Meditech
Among other players domestic and global, Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Cell Therapy Market Overview
1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Type
1.2.1 Global Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell Therapy Revenue Market Share by Type in 2019
1.2.3 Stem Cell
1.2.4 Non-Stem Cell
1.3 Global Cell Therapy Market by Application
1.3.1 Overview: Global Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Cell Therapy Market by Regions
1.4.1 Global Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Beike Biotechnology
2.2.1 Beike Biotechnology Details
2.2.2 Beike Biotechnology Major Business
2.2.3 Beike Biotechnology SWOT Analysis
2.2.4 Beike Biotechnology Product and Services
2.2.5 Beike Biotechnology Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Vericel Corporation
2.3.1 Vericel Corporation Details
2.3.2 Vericel Corporation Major Business
2.3.3 Vericel Corporation SWOT Analysis
2.3.4 Vericel Corporation Product and Services
2.3.5 Vericel Corporation Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 JCR Pharmaceuticals
2.5.1 JCR Pharmaceuticals Details
2.5.2 JCR Pharmaceuticals Major Business
2.5.3 JCR Pharmaceuticals SWOT Analysis
2.5.4 JCR Pharmaceuticals Product and Services
2.5.5 JCR Pharmaceuticals Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Osiris
2.6.1 Osiris Details
2.6.2 Osiris Major Business
2.6.3 Osiris Product and Services
2.6.4 Osiris Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Guanhao Biotech
2.7.1 Guanhao Biotech Details
2.7.2 Guanhao Biotech Major Business
2.7.3 Guanhao Biotech Product and Services
2.7.4 Guanhao Biotech Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fujifilm Cellular Dynamics
2.8.1 Fujifilm Cellular Dynamics Details
2.8.2 Fujifilm Cellular Dynamics Major Business
2.8.3 Fujifilm Cellular Dynamics Product and Services
2.8.4 Fujifilm Cellular Dynamics Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Vcanbio
2.9.1 Vcanbio Details
2.9.2 Vcanbio Major Business
2.9.3 Vcanbio Product and Services
2.9.4 Vcanbio Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Golden Meditech
2.10.1 Golden Meditech Details
2.10.2 Golden Meditech Major Business
2.10.3 Golden Meditech Product and Services
2.10.4 Golden Meditech Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy Players Market Share
3.2.2 Top 10 Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell Therapy Revenue and Market Share by Regions
4.2 North America Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America Cell Therapy Revenue by Countries
5.1 North America Cell Therapy Revenue by Countries (2015-2020)
5.2 USA Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Cell Therapy Revenue by Countries
6.1 Europe Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell Therapy Revenue by Countries
7.1 Asia-Pacific Cell Therapy Revenue by Countries (2015-2020)
7.2 China Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America Cell Therapy Revenue by Countries
8.1 South America Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell Therapy by Countries
9.1 Middle East & Africa Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Cell Therapy Market Forecast by Type (2019-2024)
10.3 Stem Cell Revenue Growth Rate (2015-2025)
10.4 Non-Stem Cell Revenue Growth Rate (2015-2025)
11 Global Cell Therapy Market Segment by Application
11.1 Global Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 Cell Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
12 Global Cell Therapy Market Size Forecast (2021-2025)
12.1 Global Cell Therapy Market Size Forecast (2021-2025)
12.2 Global Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US




• 英文レポート名:Global Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025
• 日本語訳:世界の細胞療法市場予測(~2025年)
• レポートコード:GIR201113827お問い合わせ(見積依頼・ご注文・質問)